Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Three drugs indicated for multiple myeloma have been added to the interaction checker

Friday 19 October 2018

Elotuzumab, lenalidomide and panobinostat are now listed in the interaction checker as cancer drugs and interactions can be found with all the comedications. 

  • Elotuzumab (Emplicti®) is a SLAMF7-directed antibody and is indicated for the treatment of multiple myeloma.
  • Lenalidomide (Revlimid®) is an immunomodulatory agent and is indicated for the treatment of multiple myeloma and mantle-cell lymphoma.
  • Panobinostat (Farydak®) is a HDAC inhibitor and is indicated for the treatment of multiple myeloma. 
ENDORSED BY
Bopa